Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Moonlake Immunotherapeutics (MLTX)

Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Moonlake Immunotherapeutics DORFSTRASSE 29 ZUG V8 6300 CHE

www.moonlaketx.com Employees: 50 P: 41-41-510-8022

Description:

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 3,237,002
Enterprise Value, $K 2,785,832
Shares Outstanding, K 63,884
Annual Sales, $ 0 K
Annual Net Income, $ -36,010 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,270 K
EBIT, $ -78,410 K
EBITDA, $ -78,400 K
60-Month Beta 1.28
% of Insider Shareholders 12.02%
% of Institutional Shareholders 93.85%
Float, K 56,205
% Float 87.98%
Short Volume Ratio 0.50

Growth:

1-Year Return 28.87%
3-Year Return 412.34%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.56 on 11/07/24
Next Earnings Date 11/12/24 [--]
Earnings Per Share ttm -0.91
EPS Growth vs. Prev Qtr -77.27%
EPS Growth vs. Prev Year -69.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MLTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.61%
Return-on-Assets % -10.36%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.20
Book Value/Share 8.30
Interest Coverage -0.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar